Interventional Oncology Devices – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific interventional oncology device market will see strong growth through 2032 driven by a large and rapidly expanding patient population, increasing popularity of minimally invasive surgeries, improving access to treatment, and growing physician acceptance of interventional oncology procedures. However, a lack of reimbursement, mixed results from clinical trials, and ongoing cost constraints in the region will remain a challenge for this market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Asia Pacific region from 2019 to 2032.

Table of contents

Interventional Oncology Devices - Market Insights - Asia Pacific (Supplemental)

Pankhil Paresh Gandhi

Pankhil Gandhi is a senior team lead within the Cardiovascular Medtech Insights team at Clarivate, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.

Contact sales Login to access report

Back to all Medtech Insights reports